{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,28]],"date-time":"2026-06-28T07:55:15Z","timestamp":1782633315436,"version":"3.54.5"},"reference-count":37,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2019,5,1]],"date-time":"2019-05-01T00:00:00Z","timestamp":1556668800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2019,5,1]],"date-time":"2019-05-01T00:00:00Z","timestamp":1556668800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2019,2,20]],"date-time":"2019-02-20T00:00:00Z","timestamp":1550620800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["jhep-reports.eu","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["JHEP Reports"],"published-print":{"date-parts":[[2019,5]]},"DOI":"10.1016\/j.jhepr.2019.02.002","type":"journal-article","created":{"date-parts":[[2019,3,27]],"date-time":"2019-03-27T15:20:47Z","timestamp":1553700047000},"page":"9-16","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":75,"title":["Liver steatosis is a strong predictor of mortality and cancer in chronic hepatitis B regardless of viral load"],"prefix":"10.1016","volume":"1","author":[{"given":"Noam","family":"Peleg","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Assaf","family":"Issachar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Orly","family":"Sneh Arbib","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michal","family":"Cohen-Naftaly","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marius","family":"Braun","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Moshe","family":"Leshno","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alon","family":"Barsheshet","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Amir","family":"Shlomai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jhepr.2019.02.002_bb0005","doi-asserted-by":"crossref","DOI":"10.1101\/cshperspect.a021410","article-title":"Hepatitis B Virus Epidemiology","volume":"5","author":"MacLachlan","year":"2015","journal-title":"Cold Spring Harb Perspect Med"},{"key":"10.1016\/j.jhepr.2019.02.002_bb0010","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1016\/j.antiviral.2015.06.008","article-title":"Chronic hepatitis B: Virology, natural history, current management and a glimpse at future opportunities","volume":"121","author":"Gish","year":"2015","journal-title":"Antiviral Res"},{"key":"10.1016\/j.jhepr.2019.02.002_bb0015","doi-asserted-by":"crossref","first-page":"661","DOI":"10.1002\/hep.23190","article-title":"Chronic hepatitis B: update 2009","volume":"50","author":"Lok","year":"2009","journal-title":"Hepatology"},{"key":"10.1016\/j.jhepr.2019.02.002_bb0020","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1001\/jama.295.1.65","article-title":"Risk of hepatocellular carcinoma across a biological gradient of serum hepatitis B virus DNA level","volume":"295","author":"Chen","year":"2006","journal-title":"JAMA"},{"key":"10.1016\/j.jhepr.2019.02.002_bb0025","doi-asserted-by":"crossref","first-page":"98","DOI":"10.1002\/hep.26180","article-title":"Long-term entecavir treatment reduces hepatocellular carcinoma incidence in patients with hepatitis B virus infection","volume":"58","author":"Hosaka","year":"2013","journal-title":"Hepatology"},{"key":"10.1016\/j.jhepr.2019.02.002_bb0030","doi-asserted-by":"crossref","first-page":"1333","DOI":"10.1111\/j.1478-3231.2012.02805.x","article-title":"Natural history of chronic hepatitis B: what exactly has REVEAL Revealed?","volume":"32","author":"Iloeje Uchenna","year":"2012","journal-title":"Liver Int"},{"key":"10.1016\/j.jhepr.2019.02.002_bb0035","doi-asserted-by":"crossref","first-page":"546","DOI":"10.1002\/hep.26385","article-title":"Prediction models of long\u2010term Cirrhosis and hepatocellular carcinoma risk in chronic hepatitis B patients: Risk scores integrating host and virus profiles","volume":"58","author":"Lee","year":"2013","journal-title":"Hepatology"},{"key":"10.1016\/j.jhepr.2019.02.002_bb0040","doi-asserted-by":"crossref","first-page":"e191","DOI":"10.1111\/j.1365-2893.2010.01427.x","article-title":"Viral level is an indicator of long\u2010term outcome of hepatitis B virus e antigen\u2010negative carriers with persistently normal serum alanine aminotransferase levels","volume":"18","author":"Nakazawa","year":"2011","journal-title":"J Viral Hepat"},{"issue":"1","key":"10.1016\/j.jhepr.2019.02.002_bb0045","doi-asserted-by":"crossref","first-page":"284","DOI":"10.1002\/hep.28280","article-title":"Antiviral therapy for chronic hepatitis B viral infection in adults: A systematic review and meta-analysis","volume":"63","author":"Lok","year":"2016","journal-title":"Hepatology"},{"key":"10.1016\/j.jhepr.2019.02.002_bb0050","doi-asserted-by":"crossref","first-page":"1361","DOI":"10.1111\/j.1440-1746.2011.06801.x","article-title":"Hepatic steatosis in hepatitis B virus infected patients: Meta\u2010analysis of risk factors and comparison with hepatitis C infected patients","volume":"26","author":"Machado Mariana","year":"2011","journal-title":"J Gastroenterol Hepatol"},{"key":"10.1016\/j.jhepr.2019.02.002_bb0055","doi-asserted-by":"crossref","first-page":"785","DOI":"10.1016\/j.jhep.2014.05.045","article-title":"Prevalence and causes of elevated serum aminotransferase levels in a population-based cohort of persons with chronic hepatitis B virus infection","volume":"61","author":"Spradling","year":"2014","journal-title":"J Hepatol"},{"key":"10.1016\/j.jhepr.2019.02.002_bb0060","doi-asserted-by":"crossref","first-page":"328","DOI":"10.1002\/hep.29367","article-title":"The diagnosis and management of nonalcoholic fatty liver disease: Practice guidance from the American Association for the Study of Liver Diseases","volume":"67","author":"Chalasani","year":"2018","journal-title":"Hepatology"},{"key":"10.1016\/j.jhepr.2019.02.002_bb0065","doi-asserted-by":"crossref","first-page":"2063","DOI":"10.1056\/NEJMra1503519","article-title":"Cause, Pathogenesis, and Treatment of Nonalcoholic Steatohepatitis","volume":"377","author":"Diehl","year":"2017","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jhepr.2019.02.002_bb0070","doi-asserted-by":"crossref","first-page":"865","DOI":"10.1002\/hep.21327","article-title":"Long-term follow-up of patients with NAFLD and elevated liver enzymes","volume":"44","author":"Ekstedt","year":"2006","journal-title":"Hepatology"},{"key":"10.1016\/j.jhepr.2019.02.002_bb0075","doi-asserted-by":"crossref","first-page":"140","DOI":"10.1016\/j.jhep.2017.09.012","article-title":"Association between non-alcoholic fatty liver disease and cancer incidence rate","volume":"68","author":"Kim","year":"2017","journal-title":"J Hepatol"},{"key":"10.1016\/j.jhepr.2019.02.002_bb0080","doi-asserted-by":"crossref","first-page":"686","DOI":"10.1038\/nrgastro.2013.171","article-title":"The global NAFLD epidemic","volume":"10","author":"Loomba","year":"2013","journal-title":"Nat Rev Gastroenterol Hepatol"},{"key":"10.1016\/j.jhepr.2019.02.002_bb0085","doi-asserted-by":"crossref","first-page":"883","DOI":"10.1111\/apt.12658","article-title":"Coincidental metabolic syndrome increases the risk of liver fibrosis progression in patients with chronic hepatitis B \u2013 a prospective cohort study with paired transient elastography examinations","volume":"39","author":"Wong","year":"2014","journal-title":"Aliment Pharmacol Ther"},{"key":"10.1016\/j.jhepr.2019.02.002_bb0090","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1136\/gut.2008.157735","article-title":"Metabolic syndrome increases the risk of liver cirrhosis in chronic hepatitis B","volume":"58","author":"Wong","year":"2009","journal-title":"Gut"},{"key":"10.1016\/j.jhepr.2019.02.002_bb0095","doi-asserted-by":"crossref","first-page":"5576","DOI":"10.1200\/JCO.2008.16.1075","article-title":"Body-Mass Index and Progression of Hepatitis B: A Population-Based Cohort Study in Men","volume":"26","author":"Yu","year":"2008","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.jhepr.2019.02.002_bb0100","doi-asserted-by":"crossref","first-page":"370","DOI":"10.1016\/j.jhep.2017.03.021","article-title":"EASL 2017 Clinical Practice Guidelines on the management of hepatitis B virus infection","volume":"67","author":"Lampertico","year":"2017","journal-title":"J Hepatol"},{"key":"10.1016\/j.jhepr.2019.02.002_bb0105","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0202393","article-title":"Noninvasive scoring systems predict hepatic and extra-hepatic cancers in patients with nonalcoholic fatty liver disease","volume":"13","author":"Peleg","year":"2018","journal-title":"PLoS One"},{"key":"10.1016\/j.jhepr.2019.02.002_bb0110","doi-asserted-by":"crossref","first-page":"945","DOI":"10.1136\/gutjnl-2017-314904","article-title":"High risk of hepatocellular carcinoma and death in patients with immune-tolerant-phase chronic hepatitis B","volume":"67","author":"Kim","year":"2018","journal-title":"Gut"},{"key":"10.1016\/j.jhepr.2019.02.002_bb0115","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1016\/S0140-6736(14)61682-2","article-title":"Global, regional, and national age-sex specific all-cause and cause-specific mortality for 240 causes of death, 1990-2013: a systematic analysis for the Global Burden of Disease Study 2013","volume":"385","author":"Mortality","year":"2015","journal-title":"Lancet"},{"key":"10.1016\/j.jhepr.2019.02.002_bb0120","doi-asserted-by":"crossref","first-page":"608","DOI":"10.1016\/j.jhep.2008.06.018","article-title":"Increased overall mortality and liver-related mortality in non-alcoholic fatty liver disease","volume":"49","author":"Ong","year":"2008","journal-title":"J Hepatol"},{"key":"10.1016\/j.jhepr.2019.02.002_bb0125","doi-asserted-by":"crossref","first-page":"369","DOI":"10.1111\/j.1440-1746.2009.06023.x","article-title":"Evidence for the insufficient evaluation and undertreatment of chronic hepatitis B infection in a predominantly low\u2010income and immigrant population","volume":"25","author":"Jung Chin","year":"2010","journal-title":"J Gastroenterol Hepatol"},{"key":"10.1016\/j.jhepr.2019.02.002_bb0130","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1097\/MCG.0000000000000132","article-title":"Chronic Hepatitis B Treatment Eligibility and Actual Treatment Rates in Patients in Community Gastroenterology and Primary Care Settings","volume":"49","author":"Nguyen","year":"2015","journal-title":"J Clin Gastroenterol"},{"key":"10.1016\/j.jhepr.2019.02.002_bb0135","doi-asserted-by":"crossref","DOI":"10.1136\/bmjgast-2015-000060","article-title":"Long-term follow-up and suboptimal treatment rates of treatment-eligible chronic hepatitis B patients in diverse practice settings: a gap in linkage to care","volume":"2","author":"Vu","year":"2015","journal-title":"BMJ Open Gastroenterol"},{"key":"10.1016\/j.jhepr.2019.02.002_bb0140","doi-asserted-by":"crossref","first-page":"454","DOI":"10.4103\/0377-4929.85074","article-title":"Steatosis in chronic hepatitis B: Prevalence and correlation with biochemical, histologic, viral, and metabolic parameters","volume":"54","author":"Rastogi","year":"2011","journal-title":"Indian J Pathol Microbiol"},{"key":"10.1016\/j.jhepr.2019.02.002_bb0145","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1111\/jvh.12766","article-title":"Inverse relationship between hepatic steatosis and hepatitis B viremia: Results of a large case\u2010control study","volume":"25","author":"Hui","year":"2017","journal-title":"J Viral Hepat"},{"key":"10.1016\/j.jhepr.2019.02.002_bb0150","doi-asserted-by":"crossref","first-page":"282","DOI":"10.1111\/j.1478-3231.2010.02423.x","article-title":"Hepatocyte metabolic signalling pathways and regulation of hepatitis B virus expression","volume":"31","author":"Bar-Yishay","year":"2011","journal-title":"Liver Int"},{"key":"10.1016\/j.jhepr.2019.02.002_bb0155","doi-asserted-by":"crossref","first-page":"1483","DOI":"10.1002\/hep.27159","article-title":"Binding of hepatitis B virus to its cellular receptor alters the expression profile of genes of bile acid metabolism","volume":"60","author":"Oehler","year":"2014","journal-title":"Hepatology"},{"key":"10.1016\/j.jhepr.2019.02.002_bb0160","doi-asserted-by":"crossref","first-page":"16003","DOI":"10.1073\/pnas.0607837103","article-title":"PGC-1 alpha controls hepatitis B virus through nutritional signals","volume":"103","author":"Shlomai","year":"2006","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.jhepr.2019.02.002_bb0165","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1016\/j.mehy.2007.08.032","article-title":"The \"metabolovirus\" model of hepatitis B virus suggests nutritional therapy as an effective anti-viral weapon","volume":"71","author":"Shlomai","year":"2008","journal-title":"Med Hypotheses"},{"key":"10.1016\/j.jhepr.2019.02.002_bb0170","doi-asserted-by":"crossref","first-page":"871","DOI":"10.1038\/sj.ijo.0803479","article-title":"Does increased body mass index with hepatic steatosis contribute to seroclearance of hepatitis B virus (HBV) surface antigen in chronic HBV infection?","volume":"31","author":"Chu","year":"2006","journal-title":"Int J Obes (Lond)"},{"key":"10.1016\/j.jhepr.2019.02.002_bb0175","doi-asserted-by":"crossref","first-page":"1858","DOI":"10.1111\/j.1440-1746.2012.07268.x","article-title":"Fatty liver reduces hepatitis B virus replication in a genotype B hepatitis B virus transgenic mice model","volume":"27","author":"Zhang","year":"2012","journal-title":"J Gastroenterol Hepatol"},{"issue":"5","key":"10.1016\/j.jhepr.2019.02.002_bb0180","doi-asserted-by":"crossref","first-page":"438","DOI":"10.1007\/s12072-018-9877-7","article-title":"Non-alcoholic hepatic steatosis attenuates hepatitis B virus replication in an HBV-immunocompetent mouse model","volume":"12","author":"Hu","year":"2018","journal-title":"Hepatol Int"},{"key":"10.1016\/j.jhepr.2019.02.002_bb0185","doi-asserted-by":"crossref","first-page":"773","DOI":"10.1016\/j.jhep.2015.11.012","article-title":"Evaluation of APRI and FIB-4 scoring systems for non-invasive assessment of hepatic fibrosis in chronic hepatitis B patients","volume":"64","author":"Kim","year":"2016","journal-title":"J Hepatol"}],"container-title":["JHEP Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2589555919300096?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2589555919300096?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,11]],"date-time":"2025-11-11T22:22:41Z","timestamp":1762899761000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2589555919300096"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,5]]},"references-count":37,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2019,5]]}},"alternative-id":["S2589555919300096"],"URL":"https:\/\/doi.org\/10.1016\/j.jhepr.2019.02.002","relation":{},"ISSN":["2589-5559"],"issn-type":[{"value":"2589-5559","type":"print"}],"subject":[],"published":{"date-parts":[[2019,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Liver steatosis is a strong predictor of mortality and cancer in chronic hepatitis B regardless of viral load","name":"articletitle","label":"Article Title"},{"value":"JHEP Reports","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jhepr.2019.02.002","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2019 The Author(s). Published by Elsevier B.V. on behalf of European Association for the Study of the Liver (EASL).","name":"copyright","label":"Copyright"}]}}